Posttherapy [18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome.
about
Imaging radiation response in tumor and normal tissue.¹⁸F-FDG PET/CT following chemoradiation of uterine cervix cancer provides powerful prognostic stratification independent of HPV status: a prospective cohort of 105 women with mature survival data.The Role of (18) F-FDG PET/CT in Assessing Therapy Response in Cervix Cancer after Concurrent Chemoradiation Therapy.Surveillance FDG-PET detection of asymptomatic recurrences in patients with cervical cancer.Role of New Functional MRI Techniques in the Diagnosis, Staging, and Followup of Gynecological Cancer: Comparison with PET-CT.The role of FDG-PET/CT in gynaecological cancers.Loss of the respiratory enzyme citrate synthase directly links the Warburg effect to tumor malignancy.Positron emission tomography: clinical applications in oncology. Part 2.Positron emission tomography in gynecological malignancies.Application of FDG-PET/CT in Radiation Oncology.Temporal analysis of intratumoral metabolic heterogeneity characterized by textural features in cervical cancer.The prognostic value of PET and PET/CT in cervical cancerPET and PET-CT imaging of gynecological malignancies: present role and future promise.MRI and PET scans for primary staging and detection of cervical cancer recurrence.Impact of post-therapy positron emission tomography on prognostic stratification and surveillance after chemoradiotherapy for cervical cancer.Functional imaging for assessing tumor response in cancer of the cervix.Functional imaging to predict tumor response in locally advanced cervical cancer.Evaluating PET-CT in the detection and management of recurrent cervical cancer: systematic reviews of diagnostic accuracy and subjective elicitation.Present and future role of FDG-PET/CT imaging in the management of gynecologic malignancies.FDG PET-CT of gynecologic cancers: pearls and pitfalls.Radiotherapy response evaluation using FDG PET-CT-established and emerging applications.PET Radiomics in NSCLC: state of the art and a proposal for harmonization of methodology.Identification of a serum-induced transcriptional signature associated with metastatic cervical cancer.Exploring feature-based approaches in PET images for predicting cancer treatment outcomes.Prognostic implications of post-therapy (18)F-FDG PET in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy.Do clinical characteristics and metabolic markers detected on positron emission tomography/computerized tomography associate with persistent disease in patients with in-operable cervical cancer?What's New in Imaging for Gynecologic Cancer?Glut-1 expression in small cervical biopsies is prognostic in cervical cancers treated with chemoradiation.The role of 18F-FDG PET CT in common gynaecological malignancies.Unabsorbed polylactide adhesion barrier mimicking recurrence of gynecologic malignant diseases with increased ¹⁸F-FDG uptake on PET/CT.Treatment outcomes of patients with cervical cancer with complete metabolic responses after definitive chemoradiotherapy.Follow-up after chemoradiation for cervical cancer: Why?18F-fluorodeoxyglucose positron emission tomography for predicting tumor response to radiochemotherapy in nasopharyngeal carcinoma.Comparative Study of Positron Emission Tomography/Computed Tomography and Computed Tomography in the Evaluation of Post-treatment Carcinoma Cervix Patients.Prognostic value of posttreatment F-FDG PET/CT and predictors of metabolic response to therapy in patients with locally advanced cervical cancer treated with concomitant chemoradiation therapy: an analysis of intensity- and volume-based PET parameter
P2860
Q26798266-EA315727-A3C6-4A6B-8CBB-8B0A31B47146Q30980315-D98FD611-A252-41B4-A7CA-7E489097015FQ33639390-47FAA12B-2EBB-446B-B562-CAF53673C551Q35430839-A1D45DC9-2703-4041-8B64-4D7B3FCA9958Q35725661-14E168D7-2A14-46A4-8D2E-EA24C11229D2Q35909482-502B000C-B070-4285-A3D4-41D066452190Q36382575-051071C7-29B8-4893-8C9C-C6B391DD64BEQ36448703-42D80F2A-564D-4632-BA86-B38956D4E302Q36532097-353B5345-2567-4861-A903-A6702B374AAFQ36756445-149BEDCF-95B4-488F-BDB4-B9DB0732F2EEQ36763115-86892473-5076-4A6F-A00B-906C88742337Q36836254-CC35457E-5725-413D-B474-5A99E06749D3Q37357297-C2D47992-2A05-49D4-958A-0803B8195D23Q37699364-A78F320A-DDDA-4656-B2D9-CBC588ABA7E3Q37848781-B57A5741-812D-412B-8459-5FBDB3D61188Q37905821-80D1335B-576E-45A8-967B-03CA4C584FF5Q38151507-57072AEC-4FEC-404E-B152-A0571AFB2BAAQ38168285-F7A5F528-1AD2-4F58-90FB-0204EA49CDB7Q38205397-ACFA1EBB-338A-4163-9A82-4B1BF02463E0Q38354950-453BEDEB-02D9-406D-854C-756900CAA929Q39051286-EFF56566-F920-449A-A8C8-305205CA2892Q39197536-8AB6A5C0-47A9-409B-A9A8-59785B7263ACQ41561518-86A15818-FD03-49CD-A176-05C1C3553C51Q41790286-E50FF10E-E24D-41F0-B28F-269B2E5A2E35Q43527360-85B8961D-A6F6-4A7D-B27D-6FAAAB310ADBQ44435039-BE4F4305-3260-494B-ADCD-300262D81B2AQ50145613-F37F6FAB-0BA7-4F3D-A047-80C7DD6057E6Q52794306-9E8E669E-5C3F-45A9-9B5E-1797EDB0A869Q52936161-5119FEF7-51CA-4CCB-A676-2716C6F5DEF0Q53032201-A1DBD25A-B3C2-45AB-887C-EB89638FD232Q53094712-862D3AB3-1EA7-40C2-8F0D-519B9B83B61FQ53239557-C2383FBF-2ED0-4156-AA36-9F4A71F48E68Q53504098-8A659B85-578E-4161-ACBF-6768E237F11BQ55364165-37B1146D-F6D5-435C-8F46-5FFBCF989D4CQ56349857-F99AA4F7-B06B-4A70-B28E-9FE515A60D7A
P2860
Posttherapy [18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Posttherapy [18F] fluorodeoxyg ...... cervix: response and outcome.
@ast
Posttherapy [18F] fluorodeoxyg ...... cervix: response and outcome.
@en
type
label
Posttherapy [18F] fluorodeoxyg ...... cervix: response and outcome.
@ast
Posttherapy [18F] fluorodeoxyg ...... cervix: response and outcome.
@en
prefLabel
Posttherapy [18F] fluorodeoxyg ...... cervix: response and outcome.
@ast
Posttherapy [18F] fluorodeoxyg ...... cervix: response and outcome.
@en
P2093
P356
P1476
Posttherapy [18F] fluorodeoxyg ...... cervix: response and outcome.
@en
P2093
Barry A Siegel
Farrokh Dehdashti
Imran Zoberi
Janet Rader
Perry W Grigsby
P304
P356
10.1200/JCO.2004.09.035
P407
P577
2004-06-01T00:00:00Z